EMFOSIK-M 12.5/500
March 28, 2026
GINOBOLT-M1
March 28, 2026
EMFOSIK-L 10/5
₹3,850.00
Composition:
Empagliflozin 10 mg, Linagliptin 5 mg
Packaging Detail:
10 x 10
Description
A combination tablet for type 2 diabetes combining Empagliflozin (an SGLT2 inhibitor) and Linagliptin (a DPP-4 inhibitor). These two medicines work through different mechanisms to improve glycemic control.
Indications
Indications
-
Type 2 diabetes mellitus when treatment with both Empagliflozin and Linagliptin is appropriate.
-
As an adjunct to diet and exercise to improve glycemic control.
Side Effects
Side Effects
-
Genital fungal infections.
-
Urinary tract infections.
-
Nasopharyngitis (common cold symptoms).
-
Increased urination.
-
Joint pain (arthralgia).
Reviews 0
Related products
-
CEFIMOX-200 LB
₹1,500.00 -
BECOMEL A TO Z
₹1,100.00 -
ACEFOX-SP
₹955.00
Reviews
There are no reviews yet.